These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


669 related items for PubMed ID: 17042681

  • 1. Study of serum antibodies against three eye muscle antigens and the connective tissue antigen collagen XIII in patients with Graves' disease with and without ophthalmopathy: correlation with clinical features.
    Gopinath B, Musselman R, Adams CL, Tani J, Beard N, Wall JR.
    Thyroid; 2006 Oct; 16(10):967-74. PubMed ID: 17042681
    [Abstract] [Full Text] [Related]

  • 2. Cloning and characterization of the novel thyroid and eye muscle shared protein G2s: autoantibodies against G2s are closely associated with ophthalmopathy in patients with Graves' hyperthyroidism.
    Gunji K, De Bellis A, Li AW, Yamada M, Kubota S, Ackrell B, Wengrowicz S, Bellastella A, Bizzarro A, Sinisi A, Wall JR.
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1641-7. PubMed ID: 10770210
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Eye muscle antibodies in Graves' ophthalmopathy: pathogenic or secondary epiphenomenon?
    Mizokami T, Salvi M, Wall JR.
    J Endocrinol Invest; 2004 Mar; 27(3):221-9. PubMed ID: 15164997
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Serum antibodies against the flavoprotein subunit of succinate dehydrogenase are sensitive markers of eye muscle autoimmunity in patients with Graves' hyperthyroidism.
    Gunji K, De Bellis A, Kubota S, Swanson J, Wengrowicz S, Cochran B, Ackrell BA, Salvi M, Bellastella A, Bizzarro A, Sinisi AA, Wall JR.
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1255-62. PubMed ID: 10199764
    [Abstract] [Full Text] [Related]

  • 8. Antibodies against calsequestrin and type XIII collagen are good markers for chronic upper eyelid retraction.
    Gopinath B, Adams CL, Musselman R, Tani J, Wall JR.
    Ocul Immunol Inflamm; 2007 Apr; 15(2):81-8. PubMed ID: 17558832
    [Abstract] [Full Text] [Related]

  • 9. Reevaluation of the prevalences of serum autoantibodies reactive with "64-kd eye muscle proteins" in patients with thyroid-associated ophthalmopathy.
    Kubota S, Gunji K, Stolarski C, Kennerdell JS, Wall J.
    Thyroid; 1998 Feb; 8(2):175-9. PubMed ID: 9510127
    [Abstract] [Full Text] [Related]

  • 10. Eye signs and serum eye muscle and collagen XIII antibodies in patients with transient and progressive thyroiditis.
    Gopinath B, Ma G, Wall JR.
    Thyroid; 2007 Nov; 17(11):1123-9. PubMed ID: 17887926
    [Abstract] [Full Text] [Related]

  • 11. The 64-kilodalton eye muscle protein is the flavoprotein subunit of mitochondrial succinate dehydrogenase: the corresponding serum antibodies are good markers of an immune-mediated damage to the eye muscle in patients with Graves' hyperthyroidism.
    Kubota S, Gunji K, Ackrell BA, Cochran B, Stolarski C, Wengrowicz S, Kennerdell JS, Hiromatsu Y, Wall J.
    J Clin Endocrinol Metab; 1998 Feb; 83(2):443-7. PubMed ID: 9467555
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Pathogenesis of thyroid eye disease - does autoimmunity against the TSH receptor explain all cases?].
    Wall JR, Lahooti H.
    Endokrynol Pol; 2011 Feb; 62 Suppl 1():1-7. PubMed ID: 22125104
    [Abstract] [Full Text] [Related]

  • 14. Autoantibodies to the flavoprotein subunit of succinate dehydrogenase: analysis of specificity in autoimmune thyroid disease.
    Kemp EH, Ridgway JN, Smith KA, Watson PF, Weetman AP.
    Clin Endocrinol (Oxf); 2000 Sep; 53(3):291-9. PubMed ID: 10971445
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A 63 kDa skeletal muscle protein associated with eye muscle inflammation in Graves' disease is identified as the calcium binding protein calsequestrin.
    Gunji K, Kubota S, Stolarski C, Wengrowicz S, Kennerdell JS, Wall JR.
    Autoimmunity; 1999 Sep; 29(1):1-9. PubMed ID: 10052680
    [Abstract] [Full Text] [Related]

  • 18. Pathogenesis of thyroid eye disease--does autoimmunity against the TSH receptor explain all cases?
    Wall JR, Lahooti H.
    Endokrynol Pol; 2010 Sep; 61(2):222-7. PubMed ID: 20464711
    [Abstract] [Full Text] [Related]

  • 19. Antibodies against striated muscle, connective tissue and nuclear antigens in patients with thyroid-associated ophthalmopathy: should Graves' disease be considered a collagen disorder?
    Kiljanski JI, Peele K, Stachura I, Pickeral J, Stolarski C, Kennerdell JS, Wall JR.
    J Endocrinol Invest; 1997 Nov; 20(10):585-91. PubMed ID: 9438915
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 34.